Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Journal of Medicinal Chemistry
|
February 7, 2024
Discovery of (4-Pyrazolyl)-2-aminopyrimidines as Potent and Selective Inhibitors of Cyclin-Dependent Kinase 2
Joshua R Hummel, Kai-Jiong Xiao, Jeffrey C Yang, et al.
Science Translational Medicine
|
October 25, 2023
DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell-mediated antitumor immunity
Michael Wichroski, Joseph Benci, Si-Qi Liu, et al.
Journal of Medicinal Chemistry
|
September 20, 2021
Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design
Ashvinikumar V Gavai, Derek Norris, George Delucca, et al.
Journal of Medicinal Chemistry
|
October 14, 2025
Design, Synthesis, and T Cell Checkpoint Combination Potential Of First-In-Class DGKα/ζ Inhibitor BMS-986408
Denise C Grünenfelder, Upender Velaparthi, Jayakumar S Warrier, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Journal of Medicinal Chemistry
|
February 7, 2024
Discovery of (4-Pyrazolyl)-2-aminopyrimidines as Potent and Selective Inhibitors of Cyclin-Dependent Kinase 2
Joshua R Hummel, Kai-Jiong Xiao, Jeffrey C Yang, et al.
Science Translational Medicine
|
October 25, 2023
DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell-mediated antitumor immunity
Michael Wichroski, Joseph Benci, Si-Qi Liu, et al.
Journal of Medicinal Chemistry
|
September 20, 2021
Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design
Ashvinikumar V Gavai, Derek Norris, George Delucca, et al.
Journal of Medicinal Chemistry
|
October 14, 2025
Design, Synthesis, and T Cell Checkpoint Combination Potential Of First-In-Class DGKα/ζ Inhibitor BMS-986408
Denise C Grünenfelder, Upender Velaparthi, Jayakumar S Warrier, et al.
Page
of 3